Skip to content

Effect of Intravenous Lidocaine on Postoperative Pain and Delirium in Elderly Patients Undergoing Spine Surgery: a double-blind trial

Effect of Intravenous Lidocaine on Postoperative Pain and Delirium in Elderly Patients Undergoing Spine Surgery: a double-blind trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095927
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postop rative Delirium, POD

Interventions

Lidocaine group:Before induction, administer a loading dose of lidocaine at 1.5 mg/kg within 15 minutes, and during the maintenance phase, administer a continuous intravenous infusion at a rate of 1.5
Control group: Before induction, administer a volume-equivalent saline solution as a loading dose within 15 minutes in the lidocaine group, and during the maintenance phase, administer an equal volume

Sponsors

The Second Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: (1) American Society of Anesthesiologists (ASA) Physical Status Classification: Grade I-III; (2) Age between 65 and 90 years; (3) Elderly patients scheduled for elective major spinal surgery. To minimize the influence of risk factors for delirium, such as the type and duration of surgery, "major spinal surgery" here specifically refers to posterior lumbar interbody fusion (PLIF) involving >2 levels of instrumented fusion. This standardizes the level of surgical trauma and postoperative analgesic requirements.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Exclusion criteria: (1) preoperative mental disorder, cognitive dysfunction or communication difficulties; (2) obvious sinus bradycardia (heart rate <50 beats/min) or other serious cardiovascular diseases; (3) symptomatic cerebrovascular disease (such as previous stroke); (4) History of liver and kidney dysfunction (lidocaine allergy).

Design outcomes

Secondary

MeasureTime frame
Assessment of Acute Postoperative Pain;Severity of delirium;Onset and duration of delirium.; Incidence of agitation during the awakening period;Incidence of intraoperative and postoperative adverse events.;Intraoperative opioid consumption dose, total opioid dose during and after surgery;Intraoperative opioid consumption dose, total opioid dose during and after surgery.;

Primary

MeasureTime frame
The incidence of delirium in the first seven days postoperative.;

Countries

China

Contacts

Public ContactDajiang Yuan/Jindi Jia

The Second Hospital of Shanxi Medical University

yuandajiang@sina.com+86 186 3617 1219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026